000710.SZ SHZ
Berry Genomics Co.,Ltd
1W: +14.2%
1M: +21.9%
3M: +38.5%
YTD: -14.4%
1Y: -26.5%
3Y: -1.8%
5Y: -64.1%
¥10.87 ($1.62)
+0.99 (+10.02%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$88M
-20.8% ▼
5Y CAGR: -6.5%
Capital Expenditures
$57M
-3.0% ▼
5Y CAGR: -28.1%
Free Cash Flow
$31M
-44.2% ▼
Dividends Paid
$9M
+43.9% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$42M
+2062.6% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $206M | -$110M | -$252M | -$427M | -$188M |
| Depreciation & Amort. | $77M | $106M | $103M | $114M | $92M |
| Stock-Based Comp. | $7M | $22M | $51M | -$11M | $0 |
| Change in Working Capital | -$161M | -$77M | -$145M | $46M | -$14M |
| Other Non-Cash Items | $24M | $190M | $304M | $390M | $199M |
| Operating Cash Flow | $161M | $94M | $21M | $111M | $88M |
| — Investing Activities — | |||||
| Capital Expenditures | -$113M | -$337M | -$73M | -$55M | -$57M |
| Acquisitions (Net) | $190M | $426K | $2M | $0 | $0 |
| Investment Purchases | -$53M | -$36M | $2 | $0 | -$172M |
| Investment Sales | $54M | $25M | $20M | $600K | $0 |
| Other Investing | $29K | $0 | $2M | $7M | $419M |
| Investing Cash Flow | $79M | -$347M | -$49M | -$47M | $190M |
| — Financing Activities — | |||||
| Net Debt Issuance | $165M | $9M | -$53M | -$43M | -$173M |
| Stock Repurchased | -$150M | -$56M | $0 | $0 | $0 |
| Dividends Paid | -$29M | -$20M | -$28M | -$15M | -$9M |
| Other Financing | -$1M | $56M | $0 | -$9M | -$57M |
| Financing Cash Flow | -$16M | $45M | -$81M | -$67M | -$238M |
| Net Change in Cash | $218M | -$211M | -$98M | -$2M | $42M |
| Cash End of Period | $628M | $417M | $318M | $316M | $358M |
| Free Cash Flow | $49M | -$243M | -$52M | $56M | $31M |